English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Sera from populations of normal adults and children as well as sera from children with systemic Haemophilus influenzae type b disease were tested for antibodies reacting with ribosomes from H. influenzae type b. Adults generally had high titers of antibody, with 90% having titers greater than 1:64. The distribution of titers approximated a normal curve. Among normal children, there was more variability between individual titers, with the median titers ranging between 1:64 and 1:128. In contrast, acute-phase sera from children with systemic H. influenzae type b disease all had titers of 1:16 or less. Two convalescent-phase sera had high titers. Absorption experiments ruled out cross-reaction between ribosomes and type b capsular material. Ribosomes from two unrelated type b strains were completely cross-reactive, whereas absorption with ribosomes from a type c strain led to significantly decreased titers in three of four sera. Absorption of sera with ribosomes from Pseudomonas aeruginosa and Streptococcus pneumoniae also decreased titers, indicating that these antibodies may have been induced by ribosomes of other bacteria.

Naturally occurring antibodies in human sera that react with Haemophilus influenzae type b ribosomal vaccine